Another study demonstrated that felodipine treatment (5 mg/kg/day, daily injection for 12 weeks) decreased high-cholesterol-diet-induced vascular inflammation factors and p-NF-κB levels in a rat model of atherosclerosis [79]. The gene discussed is NFKB1; the disease is atherosclerosis.